Fresh produce prescription aims to cut gestational diabetes in High-Risk moms
NCT ID NCT07165990
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether giving high-risk pregnant women free deliveries of fresh produce, lean protein, and whole grains—plus nutrition classes—can prevent gestational diabetes. Researchers will enroll 400 women receiving care at Harris Health clinics who are early in pregnancy and have risk factors like obesity. The program runs from enrollment through 12 weeks after birth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Food is Medicine (FIM) intervention: bi-weekly home delivery of fresh produce, lean protein, and whole grains plus nutrition education
What this could lead to
If it works, this could show that providing healthy food and education to at-risk pregnant women can prevent gestational diabetes and related complications.
What could go wrong
This is a single-site study that hasn't started yet. Results may not apply to other populations, and the intervention may not be enough to change diabetes rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Texas Health Science Center at Houston
Houston, Texas, 77006, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••